The cell biology of cryptosporidium infection

Microbes and Infection

Volumn 13, Issue 8-9, 2011, Pages 721-730

  O'Hara, Steven P ^a   Chen, Xian Ming ^b  

^a MAYO CLINIC   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cryptosporidium; Cytoskeleton; Epithelia; NF B

Indexed keywords

APICOMPLEXAN LIFE CYCLE STAGE; CELL ADHESION; CELL INVASION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; CYTOLOGY; EPITHELIUM; HOST CELL; HOST PATHOGEN INTERACTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; HOST-PARASITE INTERACTIONS; HUMANS;

CRYPTOSPORIDIUM;

EID: 79959916926     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.03.008     Document Type: Short Survey

References (99)

1. Nime F.A., Burek J.D., Page D.L., Holscher M.A., Yardley J.H. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology 1976, 70:592-598.
2. Tyzzer E.E. A sporozoan found in the peptic glands of the common mouse. Proc. Soc. Exp. Biol. Med. 1907, 12-13.
3. Ma P. Cryptosporidium and the enteropathy of immune deficiency. J. Pediatr. Gastroenterol. Nutr. 1984, 488-490.
4. Mac Kenzie W.R., Hoxie N.J., Proctor M.E., Gradus M.S., Blair K.A., Peterson D.E., Kazmierczak J.J., Addiss D.G., Fox K.R., Rose J.B., et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 1994, 331:161-167.
5. Richardson A.J., Frankenberg R.A., Buck A.C., Selkon J.B., Colbourne J.S., Parsons J.W., Mayon-White R.T. An outbreak of waterborne cryptosporidiosis in Swindon and Oxfordshire. Epidemiol. Infect. 1991, 107:485-495.
6. Farthing M.J. Clinical aspects of human cryptosporidiosis. Contrib. Microbiol. 2000, 6:50-74.
7. Tumwine J.K., Kekitiinwa A., Bakeera-Kitaka S., Ndeezi G., Downing R., Feng X., Akiyoshi D.E., Tzipori S. Cryptosporidiosis and microsporidiosis in Ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am. J. Trop. Med. Hyg. 2005, 73:921-925.
8. Nina J.M., McDonald V., Deer R.M., Wright S.E., Dyson D.A., Chiodini P.L., McAdam K.P. Comparative study of the antigenic composition of oocyst isolates of Cryptosporidium parvum from different hosts. Parasite Immunol. 1992, 14:227-232.
9. Ogunkolade B.W., Robinson H.A., McDonald V., Webster K., Evans D.A. Isoenzyme variation within the genus Cryptosporidium. Parasitol. Res. 1993, 79:385-388.
10. Ortega Y.R., Sheehy R.R., Cama V.A., Oishi K.K., Sterling C.R. Restriction fragment length polymorphism analysis of Cryptosporidium parvum isolates of bovine and human origin. J. Protozool 1991, 38:40S-41S.
11. Fayer R. General biology. Cryptosporidium and Cryptosporidiosis 2008, 1-42. CRC Press, Boca Raton. R. Fayer, L. Xiao (Eds.).
12. Okhuysen P.C., Chappell C.L., Crabb J.H., Sterling C.R., DuPont H.L. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 1999, 180:1275-1281.
13. Reduker D.W., Speer C.A., Blixt J.A. Ultrastructure of Cryptosporidium parvum oocysts and excysting sporozoites as revealed by high resolution scanning electron microscopy. J. Protozool 1985, 32:708-711.
14. Hijjawi N.S., Meloni B.P., Morgan U.M., Thompson R.C. Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture. Int. J. Parasitol. 2001, 31:1048-1055.
15. Fayer R., Leek R.G. The effects of reducing conditions, medium, pH, temperature, and time on in vitro excystation of Cryptosporidium. J. Protozool 1984, 31:567-569.
16. Reduker D.W., Speer C.A. Factors influencing excystation in Cryptosporidium oocysts from cattle. J. Parasitol. 1985, 71:112-115.
17. Robertson L.J., Campbell A.T., Smith H.V. In vitro excystation of Cryptosporidium parvum. Parasitol 1993, 106:13-19.
18. Forney J.R., Yang S., Healey M.C. Protease activity associated with excystation of Cryptosporidium parvum oocysts. J. Parasitol. 1996, 82:889-892.
19. Snelling W.J., Lin Q., Moore J.E., Millar B.C., Tosini F., Pozio E., Dooley J.S., Lowery C.J. Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa). Mol. Cell. Proteomics 2007, 6:346-355.
20. Okhuysen P.C., DuPont H.L., Sterling C.R., Chappell C.L. Arginine aminopeptidase, an integral membrane protein of the Cryptosporidium parvum sporozoite. Infect. Immun. 1994, 62:4667-4670.
21. Pollok R.C., McDonald V., Kelly P., Farthing M.J. The role of Cryptosporidium parvum-derived phospholipase in intestinal epithelial cell invasion. Parasitol. Res. 2003, 90:181-186.
22. McDonald V., McCrossan M.V., Petry F. Localization of parasite antigens in Cryptosporidium parvum-infected epithelial cells using monoclonal antibodies. Parasitol 1995, 110:259-268.
23. O'Hara S.P., Yu J.R., Lin J.J. A novel Cryptosporidium parvum antigen, CP2, preferentially associates with membranous structures. Parasitol. Res. 2004, 92:317-327.
24. Zapata F., Perkins M.E., Riojas Y.A., Wu T.W., Le Blancq S.M. The Cryptosporidium parvum ABC protein family. Mol. Biochem. Parasitol. 2002, 120:157-161.
25. Current W.L., Reese N.C. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J. Protozool 1986, 33:98-108.
26. Bjorneby J.M., Riggs M.W., Perryman L.E. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites. J. Immunol. 1990, 145:298-304.
27. Hijjawi N.S., Meloni B.P., Ng'anzo M., Ryan U.M., Olson M.E., Cox P.T., Monis P.T., Thompson R.C. Complete development of Cryptosporidium parvum in host cell-free culture. Int. J. Parasitol. 2004, 34:769-777.
28. Carreno R.A., Martin D.S., Barta J.R. Cryptosporidium is more closely related to the gregarines than to coccidia as shown by phylogenetic analysis of apicomplexan parasites inferred using small-subunit ribosomal RNA gene sequences. Parasitol. Res. 1999, 85:899-904.
29. Zhu G. Biochemistry. Cryptosporidium and Cryptosporidiosis 2008, 57-71. CRC Press, Boca Raton. R. Fayer, L. Xiao (Eds.).
30. Abrahamsen M.S., Templeton T.J., Enomoto S., Abrahante J.E., Zhu G., Lancto C.A., Deng M., Liu C., Widmer G., Tzipori S., Buck G.A., Xu P., Bankier A.T., Dear P.H., Konfortov B.A., Spriggs H.F., Iyer L., Anantharaman V., Aravind L., Kapur V. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 2004, 304:441-445.
31. Xu P., Widmer G., Wang Y., Ozaki L.S., Alves J.M., Serrano M.G., Puiu D., Manque P., Akiyoshi D., Mackey A.J., Pearson W.R., Dear P.H., Bankier A.T., Peterson D.L., Abrahamsen M.S., Kapur V., Tzipori S., Buck G.A. The genome of Cryptosporidium homins. Nature 2004, 431:1107-1112.
32. Rider S.D., Zhu G. Cryptosporidium: genomic and biochemical features. Exp. Parasitol. 2010, 124:2-9.
33. Soldati D., Dubremetz J.F., Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int. J. Parasitol. 2001, 31:1293-1302.
34. Hamer D.H., Ward H., Tzipori S., Pereira M.E., Alroy J.P., Keusch G.T. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect. Immun. 1994, 62:2208-2213.
35. Joe A., Verdon R., Tzipori S., Keusch G.T., Ward H.D. Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect. Immun. 1998, 66:3429-3432.
36. Chen X.M., LaRusso N.F. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterol 2000, 118:368-379.
37. Joe A., Hamer D.H., Kelley M.A., Pereira M.E., Keusch G.T., Tzipori S., Ward H.D. Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J. Euk. Microbiol. 1994, 41:44S.
38. Cevallos A.M., Zhang X., Waldor M.K., Jaison S., Zhou X., Tzipori S., Neutra M.R., Ward H.D. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect. Immun. 2000, 68:4108-4116.
39. Wanyiri J.W., Techasintana P., O'Connor R.M., Blackman M.J., Kim K., Ward H.D. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro. Eukariot. Cell 2009, 8:470-477.
40. Doyle P.S., Crabb J., Petersen C. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect. Immun. 1993, 61:4079-4084.
41. Riggs M.W., Stone A.L., Yount P.A., Langer R.C., Arrowood M.J., Bentley D.L. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol. 1997, 158:1787-1795.
42. Bhat N., Joe A., PereiraPerrin M., Ward H.D. Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro. J. Biol. Chem. 2007, 282:34877-34887.
43. O'Connor R.M., Burns P.B., Ha-Ngoc T., Scarpato K., Khan W., Kang G., Ward H. Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Cryptosporidium parvum infection in vitro. Eukariot. Cell 2009, 8:461-469.
44. Hashim A., Mulcahy G., Bourke B., Clyne M. Interaction of Cryptosporidium homins and Cryptosporidium parvum with primary human and bovine intestinal cells. Infect. Immun. 2006, 74:99-107.
45. Nesterenko M.V., Woods K., Upton S.J. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell. Biochim. Biophys. Acta 1999, 1454:165-173.
46. Kappe S.H., Buscaglia C.A., Bergman L.W., Coppens I., Nussenzweig V. Apicomplexan gliding motility and host cell invasion: overhauling the motor model. Trends Parasitol. 2004, 20:13-16.
47. Sibley L.D. Intracellular parasite invasion strategies. Science 2004, 304:248-253.
48. Dubremetz J.F., Rodriguez C., Ferreira E. Toxoplasma gondii: redistribution of monoclonal antibodies on tachyzoites during host cell invasion. Exp. Parasitol. 1985, 59:24-32.
49. Stewart M.J., Vanderberg J.P. Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J. Protozool 1988, 35:389-393.
50. Dobrowolski J.M., Sibley L.D. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 1996, 84:933-939.
51. Entzeroth R., Zgrzebski G., Dubremetz J.F. Secretion of trials during gliding motility of Eimeria nieschulzi (Apicomplexa, Coccidia) sporozoites visualized by a monoclonal antibody and immuno-gold-silver enhancement. Parasitol. Res. 1989, 76:174-175.
52. Arrowood M.J., Sterling C.R., Healey M.C. Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. J. Parasitol. 1991, 77:315-317.
53. Naitza S., Spano F., Robson K.J., Crisanti A. The thrombospondin-related protein family of apicomplexan parasites: the Gears of the cell invasion machinery, Parasitol. Today 1998, 14:479-484.
54. Robson K.J., Hall J.R., Jennings M.W., Harris T.J., Marsh K., Newbold C.I., Tate V.E., Weatherall D.J. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 1988, 335:79-82.
55. Wan K.L., Carruthers V.B., Sibley L.D., Ajioka J.W. Molecular characterisation of an expressed sequence tag locus of Toxoplasma gondii encoding the micronemal protein MIC2. Mol. Biochem. Parasitol. 1997, 84:203-214.
56. Spano F., Putignani L., Naitza S., Puri C., Wright S., Crisanti A. Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. Mol. Biochem. Parasitol. 1998, 92:147-162.
57. Deng M., Templeton T.J., London N.R., Bauer C., Schroeder A.A., Abrahamsen M.S. Cryptosporidium parvum genes containing thrombospondin type 1 domains. Infect. Immun. 2002, 70:6987-6995.
58. Huang B.Q., Chen X.M., LaRusso N.F. Cryptosporidium parvum attachment to and internalization by human biliary epithelia in vitro: a morphologic study. J. Parasitol. 2004, 90:212-221.
59. Bonnin A., Lapillonne A., Petrella T., Lopez J., Chaponnier C., Gabbiani G., Robine S., Dubremetz J.F. Immunodetection of the microvillous cytoskeleton molecules villin and ezrin in the parasitophorous vacuole wall of Cryptosporidium parvum (Protozoa: apicomplexa). Eur. J. Cell Biol. 1999, 78:794-801.
60. Elliott D.A., Clark D.P. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect. Immun. 2000, 68:2315-2322.
61. Forney J.R., DeWald D.B., Yang S., Speer C.A., Healey M.C. A role for host phosphoinositide 3-kinase and cytoskeletal remodeling during Cryptosporidium parvum infection. Infect. Immun. 1999, 67:844-852.
62. Elliott D.A., Coleman D.J., Lane M.A., May R.C., Machesky L.M., Clark D.P. Cryptosporidium parvum infection requires host cell actin polymerization. Infect. Immun. 2001, 69:5940-5942.
63. Chen X.M., Huang B.Q., Splinter P.L., Cao H., Zhu G., McNiven M.A., LaRusso N.F. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src. Gastroenterology 2003, 125:216-228.
64. Chen X.M., Splinter P.L., Tietz P.S., Huang B.Q., Billadeau D.D., LaRusso N.F. Phosphatidylinositol 3-kinase and frabin mediate Cryptosporidium parvum cellular invasion via activation of Cdc42. J. Biol. Chem. 2004, 279:31671-31678.
65. Nelson J.B., O'Hara S.P., Small A.J., Tietz P.S., Choudhury A.K., Pagano R.E., Chen X.M., LaRusso N.F. Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains. Cell. Microbiol. 2006, 8:1932-1945.
66. O'Hara S.P., Gajdos G.B., Trussoni C.E., Splinter P.L., LaRusso N.F. Cholangiocyte myosin IIB is required for localized aggregation of sodium glucose cotransporter 1 to sites of Cryptosporidium parvum cellular invasion and facilitates parasite internalization. Infect. Immun. 2010, 78:2927-2936.
67. Chen X.M., O'Hara S.P., Huang B.Q., Splinter P.L., Nelson J.B., LaRusso N.F. Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion. Proc. Natl. Acad. Sci. U S A 2005, 102:6338-6343.
68. Yu L.C., Huang C.Y., Kuo W.T., Sayer H., Turner J.R., Buret A.G. SGLT-1-mediated glucose uptake protects human intestinal epithelial cells against Giardia duodenalis-induced apoptosis. Int. J. Parasitol. 2008, 38:923-934.
69. Buret A.G., Chin A.C., Scott K.G. Infection of human and bovine epithelial cells with Cryptosporidium andersoni induces apoptosis and disrupts tight junctional ZO-1: effects of epidermal growth factor. Int. J. Parasitol. 2003, 33:1363-1371.
70. Zhang Y., Lee B., Thompson M., Glass R., Cama R.I., Figueroa D., Gilman R., Taylor D., Stephenson C. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and Cryptosporidium. Diarrhea Working Group, Peru. J. Pediat. Gastroenterol. Nutr. 2000, 31:16-21.
71. Roche J.K., Martins C.A., Cosme R., Fayer R., Guerrant R.L. Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes. Infect. Immun. 2000, 68:5635-5644.
72. Deng M., Lancto C.A., Abrahamsen M.S. Cryptosporidium parvum regulation of human epithelial cell gene expression. Int. J. Parasitol. 2004, 34:73-82.
73. Widmer G., Corey E.A., Stein B., Griffiths J.K., Tzipori S. Host cell apoptosis impairs Cryptosporidium parvum development in vitro. J. Parasitol. 2000, 86:922-928.
74. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782-784.
75. Orange J.S., Levy O., Geha R.S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol. Rev. 2005, 203:21-37.
76. Chen X.M., Levine S.A., Tietz P., Krueger E., McNiven M.A., Jefferson D.M., Mahle M., LaRusso N.F. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatol 1998, 28:906-913.
77. McCole D.F., Eckmann L., Laurent F., Kagnoff M.F. Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect. Immun. 2000, 68:1710-1713.
78. Chen X.M., Gores G.J., Paya C.V., LaRusso N.F. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am. J. Physiol. 1999, 277:G599-G608.
79. Laurent F., Eckmann L., Savidge T.C., Morgan G., Theodos C., Naciri M., Kagnoff M.F. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 1997, 65:5067-5073.
80. Seydel K.B., Zhang T., Champion G.A., Fichtenbaum C., Swanson P.E., Tzipori S., Griffiths J.K., Stanley S.L. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect. Immun. 1998, 66:2379-2382.
81. Castellanos-Gonzalez A., Yancey L.S., Wang H.C., Pantenburg B., Liscum K.R., Lewis D.E., White A.C. Cryptosporidium infection of human intestinal epithelial cells increases expression of osteoprotegerin: a novel mechanism for evasion of host defenses. J. Infect. Dis. 2008, 197:916-923.
82. Maillot C., Gargala G., Delaunay A., Ducrotte P., Brasseur P., Ballet J.J., Favennec L. Cryptosporidium parvum infection stimulates the secretion of TGF-beta, IL-8 and RANTES by Caco-2 cell line. Parasitol. Res. 2000, 86:947-949.
83. Wang H.C., Dann S.M., Okhuysen P.C., Lewis D.E., Chappell C.L., Adler D.G., White A.C. High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect. Immun. 2007, 75:481-487.
84. Chen W., Harp J.A., Harmsen A.G., Havell E.A. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect. Immun. 1993, 61:3548-3551.
85. Leav B.A., Yoshida M., Rogers K., Cohen S., Godiwala N., Blumberg R.S., Ward H. An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice. Infect. Immun. 2005, 73:8425-8428.
86. Robinson P., Okhuysen P.C., Chappell C.L., Lewis D.E., Shahab I., Janecki A., White A.C. Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms. Infect. Immun. 2001, 69:1172-1174.
87. Robinson P., Okhuysen P.C., Chappell C.L., Weinstock J.V., Lewis D.E., Actor J.K., White A.C. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J. Infect. Dis. 2003, 188:290-296.
88. Ansel J.C., Brown J.R., Payan D.G., Brown M.A. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J. Immunol. 1993, 150:4478-4485.
89. Cuesta M.C., Quintero L., Pons H., Suarez-Roca H. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem. Int. 2002, 40:301-306.
90. Tarver A.P., Clark D.P., Diamond G., Russell J.P., Erdjument-Bromage H., Tempst P., Cohen K.S., Jones D.E., Sweeney R.W., Wines M., Hwang S., Bevins C.L. Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect. Immun. 1998, 66:1045-1056.
91. Chen X.M., O'Hara S.P., Nelson J.B., Splinter P.L., Small A.J., Tietz P.S., Limper A.H., LaRusso N.F. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J. Immunol. 2005, 175:7447-7456.
92. Rogers K.A., Rogers A.B., Leav B.A., Sanchez A., Vannier E., Uematsu S., Akira S., Golenbock D., Ward H.D. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect. Immun. 2006, 74:549-556.
93. Robinson P., Okhuysen P.C., Chappell C.L., Lewis D.E., Shahab I., Lahoti S., White A.C. Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans. Infect. Immun. 2000, 68:5405-5407.
94. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
95. Sevignani C., Calin G.A., Siracusa L.D., Croce C.M. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm. Genome 2006, 17:189-202.
96. Chen X.M., Splinter P.L., O'Hara S.P., LaRusso N.F. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 2007, 282:28929-28938.
97. Hu G., Zhou R., Liu J., Gong A.Y., Eischeid A.N., Dittman J.W., Chen X.M. MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J. Immunol. 2009, 183:1617-1624.
98. Zhou R., Hu G., Liu J., Gong A.Y., Drescher K.M., Chen X.M. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog. 2009, 5:e1000681.
99. Agnew D.G., Lima A.A., Newman R.D., Wuhib T., Moore R.D., Guerrant R.L., Sears C.L. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J. Infect. Dis. 1998, 177:754-760.